A leukemia drug kills cancerous T-cells while sparing normal immunity
Wednesday, January 25, 2012 - 10:00
in Biology & Nature
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell. This cancer can involve the skin and other organs, and patients often die within three years.